Barclays
YCBD.PRA

Barclays’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History

Barclays’s Portfolio YCBD.PRA Stock Details YCBD.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,000
Closed -$3.9K – 5644
2024
Q4 		$3.9K Hold
5,000
– – ﹤0.01% 5071
2024
Q3 		$3.17K Hold
5,000
– – ﹤0.01% 5056
2024
Q2 		$3.1K Buy
+5,000
New +$3.41K ﹤0.01% 4612

Other funds holding YCBD.PRA

MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays's YCBD.PRA Position: Q1 2025 in Review

Barclays sold out of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) in Q1 2025, closing a stake of 5,000 shares — an estimated $3.9K sold.

Barclays first reported a position in YCBD.PRA in Q2 2024 and held it in 3 quarters. The position peaked at $3.9K in Q4 2024. 6 funds tracked by Wall St. Rank hold YCBD.PRA as of Q1 2025.

  • Barclays reported no remaining cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 5,000 cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock shares in Q1 2025, an estimated $3.9K.
  • Barclays first reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in Q2 2024 and held it in 3 quarters.
  • Barclays's cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position peaked at $3.9K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.